UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

Cancer research communications, 2024-04, Vol.4 (4), p.1165-1173

2024

Volltextzugriff (PDF)

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

Breast cancer research and treatment, 2012-10, Vol.135 (3), p.875-883

2012

Volltextzugriff (PDF)

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2020-09, Vol.38 (25), p.2849-2861

2020

Volltextzugriff (PDF)

Understanding diagnostic disagreement in angle closure assessment between anterior segment optical coherence tomography and gonioscopy

British journal of ophthalmology, 2020-06, Vol.104 (6), p.795-799

2020

Volltextzugriff (PDF)

Diagnostic accuracy of swept source optical coherence tomography classification algorithms for detection of gonioscopic angle closure

British journal of ophthalmology, 2022-12, Vol.106 (12), p.1716-1721

2022

Volltextzugriff (PDF)

Assessment of Circumferential Angle Closure with Swept-Source Optical Coherence Tomography: a Community Based Study

American journal of ophthalmology, 2019-03, Vol.199, p.133-139

2019

Volltextzugriff (PDF)

Angle closure extent, anterior segment dimensions and intraocular pressure

British journal of ophthalmology, 2023-07, Vol.107 (7), p.927-934

2023

Volltextzugriff (PDF)

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia

Haematologica (Roma), 2021-09, Vol.106 (9), p.2364-2373

2021

Volltextzugriff (PDF)

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Cancer discovery, 2020-03, Vol.10 (3), p.394-405

2020

Volltextzugriff (PDF)

Necrotising soft tissue infection in western Sydney: An 8‐year experience

ANZ journal of surgery, 2021-09, Vol.91 (9), p.1813-1818

2021

Volltextzugriff (PDF)

Investigating the determinants of iridolenticular contact area: a novel parameter for angle closure

British journal of ophthalmology, 2024-07, Vol.108 (7), p.940-945

2024

Volltextzugriff (PDF)

Evaluation of meridional scans for angle closure assessment with anterior segment swept-source optical coherence tomography

British journal of ophthalmology, 2021-01, Vol.105 (1), p.131-134

2021

Volltextzugriff (PDF)

Online Learning: A Post Covid-19 Alternative Pedagogy For University Students

Asian Journal of University Education, 2020-12, Vol.16 (4), p.137

2020

Volltextzugriff (PDF)

Long-chain polyunsaturated fatty acid biosynthesis in a land-crab with advanced terrestrial adaptations: Molecular cloning and functional characterization of two fatty acyl elongases

Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2022-10, Vol.262, p.110773-110773, Article 110773

2022

Volltextzugriff (PDF)

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

Breast cancer research and treatment, 2014-06, Vol.145 (3), p.725-734

2014

Volltextzugriff (PDF)

First in human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced urothelial carcinoma (UC) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS593-TPS593

2023

Volltextzugriff (PDF)

Systematic comparison of plasma EBV DNA, anti‐EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma

International journal of cancer, 2020-04, Vol.146 (8), p.2336-2347

2020

Volltextzugriff (PDF)

Intelligent entrepreneurship and firm performance: A cross-cultural investigation

Journal of international entrepreneurship, 2019-12, Vol.17 (4), p.475-493

2019

Volltextzugriff (PDF)

Cigarette price and other factors associated with brand choice and brand loyalty in Zambia: findings from the ITC Zambia Survey

Tobacco control, 2015-07, Vol.24 (Suppl 3), p.iii33-iii40

2015

Volltextzugriff (PDF)

First in human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced cholangiocarcinoma (CCA) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS637-TPS637

2023

Volltextzugriff (PDF)

Abstract CT129: ARC-3: Updated results of etrumadenant (AB928) + modified FOLFOX-6 (mFOLFOX-6) in metastatic colorectal cancer (mCRC) patients

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT129-CT129

2021

Volltextzugriff (PDF)

ARC-9: Phase Ib/II study to evaluate etrumadenant (AB928)-based treatment combinations in patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.TPS150-TPS150

2021

Volltextzugriff (PDF)

New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors

Journal of enzyme inhibition and medicinal chemistry, 2021-01, Vol.36 (1), p.627-639

2021

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Understanding diagnostic disagreement in angle closure assessment between anterior segment optical coherence tomography and gonioscopy

Diagnostic accuracy of swept source optical coherence tomography classification algorithms for detection of gonioscopic angle closure

Assessment of Circumferential Angle Closure with Swept-Source Optical Coherence Tomography: a Community Based Study

Angle closure extent, anterior segment dimensions and intraocular pressure

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Necrotising soft tissue infection in western Sydney: An 8‐year experience

Investigating the determinants of iridolenticular contact area: a novel parameter for angle closure

Evaluation of meridional scans for angle closure assessment with anterior segment swept-source optical coherence tomography

Online Learning: A Post Covid-19 Alternative Pedagogy For University Students

Long-chain polyunsaturated fatty acid biosynthesis in a land-crab with advanced terrestrial adaptations: Molecular cloning and functional characterization of two fatty acyl elongases

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

First in human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced urothelial carcinoma (UC) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations

Systematic comparison of plasma EBV DNA, anti‐EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma

Salvage Boron Neutron Capture Therapy for Malignant Brain Tumor Patients in Compliance with Emergency and Compassionate Use: Evaluation of 34 Cases in Taiwan

Intelligent entrepreneurship and firm performance: A cross-cultural investigation

Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease

Cigarette price and other factors associated with brand choice and brand loyalty in Zambia: findings from the ITC Zambia Survey

First in human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced cholangiocarcinoma (CCA) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations

Abstract CT129: ARC-3: Updated results of etrumadenant (AB928) + modified FOLFOX-6 (mFOLFOX-6) in metastatic colorectal cancer (mCRC) patients

ARC-9: Phase Ib/II study to evaluate etrumadenant (AB928)-based treatment combinations in patients with metastatic colorectal cancer (mCRC)

New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors

Suchergebnisse filtern